Ameriprise’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Ameriprise’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-840	Closed	–	–	5061
2014 Q3	$0	Hold	840	–	–	﹤0.01%	6011
2014 Q2	$1K	Hold	840	–	–	﹤0.01%	5469
2014 Q1	$2K	Hold	840	–	–	﹤0.01%	5100
2013 Q4	$1K	Hold	840	–	–	﹤0.01%	5057
2013 Q3	$2K	Hold	840	–	–	﹤0.01%	5435
2013 Q2	$2K	Buy	+840	New	+$2.32K	﹤0.01%	5354

Other funds holding ONCY

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Ameriprise's ONCY Position: Q4 2014 in Review

Ameriprise sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2014, closing a stake of 840 shares.

Ameriprise first reported a position in ONCY in Q2 2013 and held it in 6 quarters. The position peaked at $2K in Q1 2014. 33 funds tracked by Wall St. Rank hold ONCY as of Q4 2014.

Ameriprise reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2014 after selling out during the quarter.
Ameriprise sold 840 ONCOLYTICS BIOTECH INC shares in Q4 2014.
Ameriprise first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 6 quarters.
Ameriprise's ONCOLYTICS BIOTECH INC position peaked at $2K in Q1 2014.
33 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.